FDA Approved: STIMUFEND — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for STIMUFEND (PEGFLILGRASTIM-FPGK) from Fresenius Kabi USA, LLC, expanding/confirming labeling to support use in reduci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Neutropenia
• Chemotherapy-induced Neutropenia
• Neutropenia

Drugs mentioned

• STIMUFEND (PEGFLILGRASTIM-FPGK)

Snippet

SUPPL AP for STIMUFEND (PEGFLILGRASTIM-FPGK)